FINWIRES · TerminalLIVE
FINWIRES

LifeSci Capital Initiates Satellos Bioscience at Outperform

By

Satellos Bioscience Inc (MSCL) has an average rating of buy and mean price target of CA$30.24, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

Related Articles